Vanguard Group’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.77M | Sell |
3,162,272
-350,927
| -10% | -$751K | ﹤0.01% | 3099 |
|
|
2025
Q1 | $4.04M | Buy |
3,513,199
+5,112
| +0.1% | +$5.88K | ﹤0.01% | 3255 |
|
|
2024
Q4 | $7.68M | Buy |
3,508,087
+40,366
| +1% | +$88.4K | ﹤0.01% | 3083 |
|
|
2024
Q3 | $7.56M | Buy |
3,467,721
+473,479
| +16% | +$1.03M | ﹤0.01% | 3094 |
|
|
2024
Q2 | $6.92M | Sell |
2,994,242
-711,230
| -19% | -$1.64M | ﹤0.01% | 3106 |
|
|
2024
Q1 | $20.4M | Sell |
3,705,472
-36,453
| -1% | -$200K | ﹤0.01% | 2588 |
|
|
2023
Q4 | $9.24M | Buy |
3,741,925
+1,079,254
| +41% | +$2.67M | ﹤0.01% | 2986 |
|
|
2023
Q3 | $92.5M | Buy |
2,662,671
+277,906
| +12% | +$9.65M | ﹤0.01% | 1847 |
|
|
2023
Q2 | $78.2M | Buy |
2,384,765
+577,060
| +32% | +$18.9M | ﹤0.01% | 1988 |
|
|
2023
Q1 | $60.6M | Buy |
1,807,705
+311,534
| +21% | +$10.4M | ﹤0.01% | 2087 |
|
|
2022
Q4 | $49.1M | Buy |
1,496,171
+392,218
| +36% | +$12.9M | ﹤0.01% | 2198 |
|
|
2022
Q3 | $38.5M | Buy |
1,103,953
+197,014
| +22% | +$6.88M | ﹤0.01% | 2306 |
|
|
2022
Q2 | $11.1M | Buy |
906,939
+430,077
| +90% | +$5.26M | ﹤0.01% | 2941 |
|
|
2022
Q1 | $6.47M | Sell |
476,862
-91
| -0% | -$1.24K | ﹤0.01% | 3392 |
|
|
2021
Q4 | $9.47M | Buy |
+476,953
| New | +$9.47M | ﹤0.01% | 3239 |
|